» Articles » PMID: 28053125

Efficient Mapping of Transgene Integration Sites and Local Structural Changes in Cre Transgenic Mice Using Targeted Locus Amplification

Overview
Specialty Biochemistry
Date 2017 Jan 6
PMID 28053125
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Cre/LoxP technology is widely used in the field of mouse genetics for spatial and/or temporal regulation of gene function. For Cre lines generated via pronuclear microinjection of a Cre transgene construct, the integration site is random and in most cases not known. Integration of a transgene can disrupt an endogenous gene, potentially interfering with interpretation of the phenotype. In addition, knowledge of where the transgene is integrated is important for planning of crosses between animals carrying a conditional allele and a given Cre allele in case the alleles are on the same chromosome. We have used targeted locus amplification (TLA) to efficiently map the transgene location in seven previously published Cre and CreERT2 transgenic lines. In all lines, transgene insertion was associated with structural changes of variable complexity, illustrating the importance of testing for rearrangements around the integration site. In all seven lines the exact integration site and breakpoint sequences were identified. Our methods, data and genotyping assays can be used as a resource for the mouse community and our results illustrate the power of the TLA method to not only efficiently map the integration site of any transgene, but also provide additional information regarding the transgene integration events.

Citing Articles

The widely used Ucp1-Cre transgene elicits complex developmental and metabolic phenotypes.

Halurkar M, Inoue O, Singh A, Mukherjee R, Ginugu M, Ahn C Nat Commun. 2025; 16(1):770.

PMID: 39824816 PMC: 11742029. DOI: 10.1038/s41467-024-54763-4.


Reducing DNA extraction costs through factorial design for the DNAdvance Kit.

Neal C, Zbinden Z, Douglas M, Douglas M BMC Res Notes. 2024; 17(1):397.

PMID: 39736778 PMC: 11684086. DOI: 10.1186/s13104-024-07063-5.


Severe neurodegeneration in brains of transgenic rats producing human tau prions.

Ayers J, Lopez T, Steele I, Oehler A, Roman-Albarran R, Cleveland E Acta Neuropathol. 2024; 148(1):25.

PMID: 39160375 PMC: 11333523. DOI: 10.1007/s00401-024-02771-5.


Benefits and Caveats in the Use of Retinal Pigment Epithelium-Specific Cre Mice.

Kocherlakota S, Baes M Int J Mol Sci. 2024; 25(2).

PMID: 38279294 PMC: 10816505. DOI: 10.3390/ijms25021293.


The widely used transgene elicits complex developmental and metabolic phenotypes.

Halurkar M, Inoue O, Mukherjee R, Bonatto Paese C, Duszynski M, Brugmann S bioRxiv. 2023; .

PMID: 37904917 PMC: 10614962. DOI: 10.1101/2023.10.20.563165.


References
1.
Uemura S, Nagaoka T, Yokoyama M, Igarashi M, Kishi M . A simple and highly efficient method to identify the integration site of a transgene in the animal genome. Neurosci Res. 2014; 80:91-4. DOI: 10.1016/j.neures.2013.11.007. View

2.
Iacovelli J, Zhao C, Wolkow N, Veldman P, Gollomp K, Ojha P . Generation of Cre transgenic mice with postnatal RPE-specific ocular expression. Invest Ophthalmol Vis Sci. 2011; 52(3):1378-83. PMC: 3101664. DOI: 10.1167/iovs.10-6347. View

3.
Bosenberg M, Muthusamy V, Curley D, Wang Z, Hobbs C, Nelson B . Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis. 2006; 44(5):262-7. DOI: 10.1002/dvg.20205. View

4.
Durkin M, Popescu N, Thorgeirsson S . Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome. Genomics. 2001; 73(1):20-7. DOI: 10.1006/geno.2001.6507. View

5.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View